Story
China Resumes Bull Semen Imports with Strict 'Top 10%' Quality Mandate

China has re-entered the global market for bull semen after a near-total halt, but is now imposing a stringent new quality standard that limits imports to genetics from the top tier of bulls. The policy is part of Beijing's strategic push to enhance its domestic cattle herds, boost food production, and curb a growing bill for imported beef and dairy products, according to a Reuters report citing industry participants.
A New Standard for Genetic Imports
After a multi-year pause that disrupted trade with top suppliers like the U.S., Europe, and Australia, China has resumed imports with a significant new condition. Government officials and genetics companies report that all shipments are now subject to a rule that restricts imports to semen from the top 10% of bulls in the country of origin.
This intensive screening process, which has not been previously reported, involves a review by an expert panel that can take over four months per shipment. The first batch under the new rules, sourced from Australia, arrived in April. Canadian suppliers are also ramping up shipments, while industry sources expect the United States and Britain could receive approval soon.
Upgrading a Nation's Herd
The drive for elite genetics reflects China's goal to improve its less productive domestic cattle. According to USDA data, beef cattle carcasses in China average around 150 kilograms, significantly less than the nearly 400 kg average in the United States. Similarly, Chinese dairy cows produce less milk than their U.S. counterparts.
AdThis initiative is also a response to shifting consumer demand. A wealthier middle class has developed a preference for higher-quality, better-marbled beef and premium dairy, causing China's annual import bill for these products to swell to between $25 billion and $30 billion. In 2021, Beijing declared self-sufficiency in animal genetics a national security priority, identifying cattle breeding as a critical weakness.
Market Implications
The previous halt in imports, which began around 2019 and coincided with political tensions, created a significant supply gap and reportedly led to a market for smuggled genetics. While trade is resuming, volumes remain low. Chinese customs data shows that by the end of August, China had received 92,573 straws of semen from Australia and Canada, a fraction of the roughly 10 million straws imported annually before the restrictions.
However, suppliers are optimistic. ABS Global's Australian arm expects to ship around 200,000 straws in the coming year. The biggest potential shift will come if the U.S. regains market access. The United States accounts for approximately 55% of the global bull semen trade and was China’s dominant supplier before the trade was frozen, positioning it to reclaim a significant market share upon re-approval.
Read next
More on Stocks
RBC Capital Markets Favors Nutrien as Geopolitical Tensions Roil Fertilizer Sector
RBC Capital Markets highlights Canadian fertilizer producer Nutrien for its relative stability, citing its diversified business model as a key advantage amid market volatility driven by energy prices and geopolitical risks.

Scotiabank Lifts CAE Price Target to C$49 on $500M Flightscape Sale
Scotiabank has increased its price target for CAE Inc. after the aviation technology firm announced the sale of its Flightscape business for US$500 million, a deal expected to significantly bolster its balance sheet.

Essential Properties Realty Trust Stock Slides on $450 Million Debt Offering Plan
Shares of the real estate investment trust fell after it announced a private placement of $450 million in exchangeable senior notes due 2032. The company plans to use the proceeds to pay down existing debt and fund capped call transactions.

Group 1 Automotive Sees $24 Million Insider Buy Amid Executive Stock Sales Elsewhere
A significant $24.2 million stock purchase by a major shareholder at Group 1 Automotive led Monday's insider activity, contrasting with multi-million dollar sales by executives at firms like Intuitive Surgical and Charles River Labs.